Genentech to highlight innovation in hemophilia, lymphoma and myeloma at ASH 2025
Genentech, a member of the Roche Group announced that it will showcase 46 abstracts, including 12 oral presentations, from its industry-leading hematology portfolio at the 67th American Society… read more.




